[Pfizer-invested DeSci project VitaDAO spins off biotechnology company Matrix Biosciences] According to Odaily Planet Daily, the DeSci (decentralized science) project VitaDAO invested by pharmaceutical giant Pfizer recently spun off a biotechnology company Matrix Biosciences. The company is led by Vera Gorbunova, an anti-aging researcher at the University of Rochester, with an initial financing of US$300,000, and more funds will be in place in early 2024. Matrix Biosciences is committed to studying the longevity and anti-cancer properties of naked mole rats, and exploring whether the compounds found in them can extend human life. What do you think of this study? Feel free to talk in the comment section! (blockworks)